PlexBio Co., Ltd. (TPEX:6572)
Taiwan
· Delayed Price · Currency is TWD 6.98
+0.05 (0.72%)
Mar 10, 2026, 10:42 AM CST
PlexBio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 153.06 | 128.06 | 167.18 | 191.19 | 124.94 | 101.35 | Upgrade
|
| Revenue Growth (YoY) | 47.69% | -23.40% | -12.56% | 53.02% | 23.28% | 42.38% | Upgrade
|
| Cost of Revenue | 103.88 | 78.8 | 104.71 | 132.19 | 86.38 | 59.67 | Upgrade
|
| Gross Profit | 49.18 | 49.26 | 62.47 | 59 | 38.56 | 41.68 | Upgrade
|
| Selling, General & Admin | 53.84 | 59.5 | 63.65 | 53.32 | 60.51 | 76.62 | Upgrade
|
| Research & Development | 57.68 | 69.29 | 62.97 | 72.61 | 113.31 | 113.37 | Upgrade
|
| Operating Expenses | 111.52 | 128.79 | 126.62 | 125.93 | 173.82 | 189.99 | Upgrade
|
| Operating Income | -62.35 | -79.53 | -64.15 | -66.94 | -135.26 | -148.31 | Upgrade
|
| Interest Expense | -0.21 | -0.16 | -0.26 | -0.17 | -0.23 | -0.23 | Upgrade
|
| Interest & Investment Income | 9.63 | 9.58 | 8.27 | 3.01 | 2.31 | 4.21 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.87 | 7.84 | -2.88 | 10.06 | -2.01 | -4.94 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.28 | 0.63 | 0.49 | 0.9 | 4.08 | 13.53 | Upgrade
|
| EBT Excluding Unusual Items | -64.51 | -61.63 | -58.53 | -53.14 | -131.11 | -135.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.48 | -5.33 | Upgrade
|
| Pretax Income | -64.51 | -61.63 | -58.53 | -53.14 | -131.59 | -141.07 | Upgrade
|
| Net Income | -64.51 | -61.63 | -58.53 | -53.14 | -131.59 | -141.07 | Upgrade
|
| Net Income to Common | -64.51 | -61.63 | -58.53 | -53.14 | -131.59 | -141.07 | Upgrade
|
| Shares Outstanding (Basic) | 104 | 104 | 104 | 104 | 104 | 103 | Upgrade
|
| Shares Outstanding (Diluted) | 104 | 104 | 104 | 104 | 104 | 103 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.11% | 0.51% | 28.99% | Upgrade
|
| EPS (Basic) | -0.62 | -0.59 | -0.56 | -0.51 | -1.27 | -1.37 | Upgrade
|
| EPS (Diluted) | -0.62 | -0.59 | -0.56 | -0.51 | -1.27 | -1.37 | Upgrade
|
| Free Cash Flow | -163.1 | -8.64 | -32.11 | -73.02 | -95.94 | -116.71 | Upgrade
|
| Free Cash Flow Per Share | -1.57 | -0.08 | -0.31 | -0.70 | -0.93 | -1.13 | Upgrade
|
| Gross Margin | 32.13% | 38.46% | 37.37% | 30.86% | 30.86% | 41.13% | Upgrade
|
| Operating Margin | -40.73% | -62.10% | -38.38% | -35.01% | -108.26% | -146.34% | Upgrade
|
| Profit Margin | -42.15% | -48.13% | -35.01% | -27.79% | -105.32% | -139.19% | Upgrade
|
| Free Cash Flow Margin | -106.56% | -6.75% | -19.21% | -38.19% | -76.78% | -115.16% | Upgrade
|
| EBITDA | -53.35 | -69.67 | -55.06 | -55.76 | -121.46 | -132.73 | Upgrade
|
| EBITDA Margin | -34.85% | -54.40% | -32.93% | -29.17% | -97.21% | -130.97% | Upgrade
|
| D&A For EBITDA | 9 | 9.86 | 9.09 | 11.17 | 13.8 | 15.58 | Upgrade
|
| EBIT | -62.35 | -79.53 | -64.15 | -66.94 | -135.26 | -148.31 | Upgrade
|
| EBIT Margin | -40.73% | -62.10% | -38.37% | -35.01% | -108.26% | -146.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.